Indication

Infantile hypophosphatasia

Infantile hypophosphatasia is a severe, early-onset form of hypophosphatasia, an inherited metabolic disorder caused by loss-of-function variants in the *ALPL* gene that result in deficient tissue-nonspecific alkaline phosphatase activity. Read more about Infantile hypophosphatasia

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Infantile hypophosphatasia therapies.

Showing 1–1 of 1 drugs

STRENSIQ (asfotase alfa)

METABOLIC DISEASE ENZYME REPLACEMENT - HYPOPHOSPHATASIA·CHILDHOOD HYPOPHOSPHATASIA·+1
ALEXION PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Infantile hypophosphatasia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Infantile hypophosphatasia.

Infantile hypophosphatasia is a severe, early-onset form of hypophosphatasia, an inherited metabolic disorder caused by loss-of-function variants in the *ALPL* gene that result in deficient tissue-nonspecific alkaline phosphatase activity.

Typically presenting between birth and six months of age, this systemic condition primarily affects the skeletal, respiratory, and central nervous systems due to impaired bone and dental mineralization.

Hallmarks include progressive rachitic skeletal deformities, flared metaphyses, rib cage instability leading to respiratory compromise, failure to thrive, hypercalcemia, and vitamin B6-dependent seizures.

Biochemically, it is characterized by paradoxically low serum alkaline phosphatase activity accompanied by elevated extracellular substrates such as inorganic pyrophosphate and pyridoxal 5'-phosphate.

Personalize your experience

Follow Infantile hypophosphatasia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it